Last edition
News about "Series B financing round"
Andera Partners participated in Exciva’s Euro 51 million Series B round to advance Deraphan into Phase II trials for agitation in Alzheimer’s disease across Europe and North America.
Series B Financing Round | 23/01/2026 | By News Bureau
Noema Pharma Closes its Series B Financing Round with USD 147 Million Capital Funding
The new financing will support Noema Pharma’s four active Phase 2 trials, with key data readouts anticipated in 2025.
Series B Financing Round | 18/12/2024 | By Aishwarya | 590
Pathalys Pharma Bags USD 105 Million in Series B Financing
The funds raised via this financing will be utilized to finalize the two ongoing upacicalcet clinical trials, execution of the NDA filing process with the US Food and Drug Administration (FDA), and acceleration of preapproval commercialization preparations.
Series B Financing Round | 21/08/2024 | By Aishwarya | 673
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy